Hunan Er-Kang Pharmaceutical Co., Ltd 300267.SZ Stock
Hunan Er-Kang Pharmaceutical Co., Ltd Price Chart
Hunan Er-Kang Pharmaceutical Co., Ltd 300267.SZ Financial and Trading Overview
| Hunan Er-Kang Pharmaceutical Co., Ltd stock price | 2.46 CNY |
| Previous Close | 3.28 CNY |
| Open | 3.27 CNY |
| Bid | 3.26 CNY x 0 |
| Ask | 3.27 CNY x 0 |
| Day's Range | 3.25 - 3.29 CNY |
| 52 Week Range | 2.96 - 4.28 CNY |
| Volume | 6.47M CNY |
| Avg. Volume | 13.84M CNY |
| Market Cap | 6.72B CNY |
| Beta (5Y Monthly) | 0.362328 |
| PE Ratio (TTM) | 163 |
| EPS (TTM) | 0.02 CNY |
| Forward Dividend & Yield | 0.03 (0.91%) |
| Ex-Dividend Date | June 9, 2023 |
| 1y Target Est | N/A |
300267.SZ Valuation Measures
| Enterprise Value | 6.42B CNY |
| Trailing P/E | 163 |
| Forward P/E | 4.179487 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.3770342 |
| Price/Book (mrq) | 1.3306122 |
| Enterprise Value/Revenue | 3.226 |
| Enterprise Value/EBITDA | 40.481 |
Trading Information
Hunan Er-Kang Pharmaceutical Co., Ltd Stock Price History
| Beta (5Y Monthly) | 0.362328 |
| 52-Week Change | -4.093% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.28 CNY |
| 52 Week Low | 2.96 CNY |
| 50-Day Moving Average | 3.32 CNY |
| 200-Day Moving Average | 3.39 CNY |
300267.SZ Share Statistics
| Avg. Volume (3 month) | 13.84M CNY |
| Avg. Daily Volume (10-Days) | 14.25M CNY |
| Shares Outstanding | 2.06B |
| Float | 913.42M |
| Short Ratio | N/A |
| % Held by Insiders | 60.30% |
| % Held by Institutions | 0.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.03 |
| Trailing Annual Dividend Yield | 0.91% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 20:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.47% |
| Operating Margin (ttm) | -0.13% |
| Gross Margin | 21.39% |
| EBITDA Margin | 7.96% |
Management Effectiveness
| Return on Assets (ttm) | -0.029% |
| Return on Equity (ttm) | 0.75% |
Income Statement
| Revenue (ttm) | 1.99B CNY |
| Revenue Per Share (ttm) | 0.97 CNY |
| Quarterly Revenue Growth (yoy) | 28.29% |
| Gross Profit (ttm) | 415.64M CNY |
| EBITDA | 158.68M CNY |
| Net Income Avi to Common (ttm) | 49.3M CNY |
| Diluted EPS (ttm) | 0.02 |
| Quarterly Earnings Growth (yoy) | 15.69% |
Balance Sheet
| Total Cash (mrq) | 540.78M CNY |
| Total Cash Per Share (mrq) | 0.26 CNY |
| Total Debt (mrq) | 204.56M CNY |
| Total Debt/Equity (mrq) | 4.05 CNY |
| Current Ratio (mrq) | 3.932 |
| Book Value Per Share (mrq) | 2.45 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 21.69M CNY |
| Levered Free Cash Flow (ttm) | 149.81M CNY |
Profile of Hunan Er-Kang Pharmaceutical Co., Ltd
| Country | China |
| State | N/A |
| City | Liuyang |
| Address | Liuyang National Eco & Technical Dev Zn |
| ZIP | N/A |
| Phone | 86 731 8465 9108 |
| Website | https://www.hnerkang.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1497 |
Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's finished drugs primarily comprise sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. The company was founded in 2003 and is based in Liuyang, China.
Q&A For Hunan Er-Kang Pharmaceutical Co., Ltd Stock
What is a current 300267.SZ stock price?
Hunan Er-Kang Pharmaceutical Co., Ltd 300267.SZ stock price today per share is 2.46 CNY.
How to purchase Hunan Er-Kang Pharmaceutical Co., Ltd stock?
You can buy 300267.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hunan Er-Kang Pharmaceutical Co., Ltd?
The stock symbol or ticker of Hunan Er-Kang Pharmaceutical Co., Ltd is 300267.SZ.
Which industry does the Hunan Er-Kang Pharmaceutical Co., Ltd company belong to?
The Hunan Er-Kang Pharmaceutical Co., Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hunan Er-Kang Pharmaceutical Co., Ltd have in circulation?
The max supply of Hunan Er-Kang Pharmaceutical Co., Ltd shares is 2.06B.
What is Hunan Er-Kang Pharmaceutical Co., Ltd Price to Earnings Ratio (PE Ratio)?
Hunan Er-Kang Pharmaceutical Co., Ltd PE Ratio is 123.00001000 now.
What was Hunan Er-Kang Pharmaceutical Co., Ltd earnings per share over the trailing 12 months (TTM)?
Hunan Er-Kang Pharmaceutical Co., Ltd EPS is 0.02 CNY over the trailing 12 months.
Which sector does the Hunan Er-Kang Pharmaceutical Co., Ltd company belong to?
The Hunan Er-Kang Pharmaceutical Co., Ltd sector is Healthcare.